Activin Receptor Type 1 Market Report

Global and China Activin Receptor Type 1 Industry Market Research Report (2017-2028)

  • POSTDATE：Oct 29, 2022
  • PAGES：142
  • REPORT CODE：GMM1326635
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Activin Receptor Type 1 industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Oncodesign SA

    • Blueprint Medicines Corp

    • Daiichi Sankyo Company Ltd

    • Tolero Pharmaceuticals Inc

    • La Jolla Pharmaceutical Company

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • LJPC-6417

    • TP-0184

    • Dipyridamole

    • Others

    Application:

    • Alport Syndrome

    • Chronic Kidney Disease

    • Kidney Fibrosis

    • Obesity

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Activin Receptor Type 1 Industry Overview

      • 1.1.1 Activin Receptor Type 1 Market Scope and Market Segments

      • 1.1.2 Activin Receptor Type 1 Industry Characteristics

      • 1.1.3 Global and China Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Activin Receptor Type 1 Production Value and Growth Rate (2017-2028)

    • 1.2 Global Activin Receptor Type 1 Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 LJPC-6417

      • 1.2.2 TP-0184

      • 1.2.3 Dipyridamole

      • 1.2.4 Others

    • 1.3 Global Activin Receptor Type 1 Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Alport Syndrome

      • 1.3.2 Chronic Kidney Disease

      • 1.3.3 Kidney Fibrosis

      • 1.3.4 Obesity

      • 1.3.5 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Activin Receptor Type 1 Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Activin Receptor Type 1 Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Activin Receptor Type 1 Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Activin Receptor Type 1 Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Activin Receptor Type 1 Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Activin Receptor Type 1 Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Activin Receptor Type 1 Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Activin Receptor Type 1 Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Activin Receptor Type 1 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Activin Receptor Type 1 Industry Porter's Five Forces Model Analysis

      • 2.2.3 Activin Receptor Type 1 Industry PEST Analysis

    • 2.3 Activin Receptor Type 1 Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Activin Receptor Type 1 Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Activin Receptor Type 1 Industry

    Chapter 3 Global and China Activin Receptor Type 1 Market, by Manufacturer

    • 3.1 Global and China Activin Receptor Type 1 Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Activin Receptor Type 1 Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Activin Receptor Type 1 Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Activin Receptor Type 1 Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Activin Receptor Type 1 Market Top 3 Players

    Chapter 4 Global and China Activin Receptor Type 1 Market, by Type (2017-2028)

    • 4.1 Activin Receptor Type 1 Market Trend, by Type

    • 4.2 Global Activin Receptor Type 1 Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Activin Receptor Type 1 Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Activin Receptor Type 1 Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Activin Receptor Type 1 Price Trend, by Type (2017-2028)

    • 4.3 China Activin Receptor Type 1 Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Activin Receptor Type 1 Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Activin Receptor Type 1 Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Activin Receptor Type 1 Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Activin Receptor Type 1 Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Activin Receptor Type 1 Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Activin Receptor Type 1 Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Activin Receptor Type 1 Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Activin Receptor Type 1 Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Activin Receptor Type 1 Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Activin Receptor Type 1 Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Activin Receptor Type 1 Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Activin Receptor Type 1 Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Activin Receptor Type 1 Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Activin Receptor Type 1 Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Activin Receptor Type 1 Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Activin Receptor Type 1 Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Activin Receptor Type 1 Market Analysis

    • 7.1 North America Activin Receptor Type 1 Market, by Type

    • 7.2 North America Activin Receptor Type 1 Market, by Application

    • 7.3 North America Activin Receptor Type 1 Market Analysis and Forecast, by Country

      • 7.3.1 United States Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Activin Receptor Type 1 Market Analysis

    • 8.1 Europe Activin Receptor Type 1 Market, by Type

    • 8.2 Europe Activin Receptor Type 1 Market, by Application

    • 8.3 Europe Activin Receptor Type 1 Market Analysis and Forecast, by Country

      • 8.3.1 Germany Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Activin Receptor Type 1 Market Analysis

    • 9.1 APAC Activin Receptor Type 1 Market, by Type

    • 9.2 APAC Activin Receptor Type 1 Market, by Application

    • 9.3 APAC Activin Receptor Type 1 Market Analysis and Forecast, by Country

      • 9.3.1 China Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Activin Receptor Type 1 Market Analysis

    • 10.1 Latin America, Middle East and Africa Activin Receptor Type 1 Market, by Type

    • 10.2 Latin America, Middle East and Africa Activin Receptor Type 1 Market, by Application

    • 10.3 Latin America, Middle East and Africa Activin Receptor Type 1 Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Activin Receptor Type 1 Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Activin Receptor Type 1 Company Profiles

      • 11.1 Oncodesign SA

        • 11.1.1 Oncodesign SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Oncodesign SA Activin Receptor Type 1 Product Profiles, Application and Specification

        • 11.1.3 Oncodesign SA Activin Receptor Type 1 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Blueprint Medicines Corp

        • 11.2.1 Blueprint Medicines Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Blueprint Medicines Corp Activin Receptor Type 1 Product Profiles, Application and Specification

        • 11.2.3 Blueprint Medicines Corp Activin Receptor Type 1 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Daiichi Sankyo Company Ltd

        • 11.3.1 Daiichi Sankyo Company Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Product Profiles, Application and Specification

        • 11.3.3 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Tolero Pharmaceuticals Inc

        • 11.4.1 Tolero Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Product Profiles, Application and Specification

        • 11.4.3 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 La Jolla Pharmaceutical Company

        • 11.5.1 La Jolla Pharmaceutical Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 La Jolla Pharmaceutical Company Activin Receptor Type 1 Product Profiles, Application and Specification

        • 11.5.3 La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Activin Receptor Type 1 Industry Investment Prospect and Risk Assessment

    • 12.1 Activin Receptor Type 1 Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Activin Receptor Type 1 Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure China Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Global Activin Receptor Type 1 Production Value and Growth Rate (2017-2028)

    • Figure China Activin Receptor Type 1 Production Value and Growth Rate (2017-2028)

    • Figure Global Activin Receptor Type 1 Market Size and Growth Rate of LJPC-6417 (2017-2028)

    • Figure Global Activin Receptor Type 1 Market Size and Growth Rate of TP-0184 (2017-2028)

    • Figure Global Activin Receptor Type 1 Market Size and Growth Rate of Dipyridamole (2017-2028)

    • Figure Global Activin Receptor Type 1 Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Activin Receptor Type 1 Market Size and Growth Rate of Alport Syndrome (2017-2028)

    • Figure Global Activin Receptor Type 1 Market Size and Growth Rate of Chronic Kidney Disease (2017-2028)

    • Figure Global Activin Receptor Type 1 Market Size and Growth Rate of Kidney Fibrosis (2017-2028)

    • Figure Global Activin Receptor Type 1 Market Size and Growth Rate of Obesity (2017-2028)

    • Figure Global Activin Receptor Type 1 Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Activin Receptor Type 1 Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Activin Receptor Type 1 Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Activin Receptor Type 1 Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Activin Receptor Type 1 Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Activin Receptor Type 1 Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Activin Receptor Type 1 Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Activin Receptor Type 1 Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Activin Receptor Type 1 Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Activin Receptor Type 1 Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Activin Receptor Type 1 Market Share, by Manufacturer in 2021

    • Figure Global and China Activin Receptor Type 1 Market Share, by Manufacturer in 2022

    • Table Global Activin Receptor Type 1 Sales Volume, by Type (2017-2028)

    • Table Global Activin Receptor Type 1 Sales Volume Share, by Type (2017-2028)

    • Figure Global Activin Receptor Type 1 Sales Volume Share, by Type (2017-2028)

    • Table Global Activin Receptor Type 1 Sales Value, by Type (2017-2028)

    • Table Global Activin Receptor Type 1 Sales Value Share, by Type (2017-2028)

    • Figure Global Activin Receptor Type 1 Price Trend, by Type (2017-2028)

    • Table China Activin Receptor Type 1 Sales Volume, by Type (2017-2028)

    • Table China Activin Receptor Type 1 Sales Volume Share, by Type (2017-2028)

    • Figure China Activin Receptor Type 1 Sales Volume Share, by Type (2017-2028)

    • Table China Activin Receptor Type 1 Sales Value, by Type (2017-2028)

    • Table China Activin Receptor Type 1 Sales Value Share, by Type (2017-2028)

    • Figure China Activin Receptor Type 1 Price Trend, by Type (2017-2028)

    • Table Global Activin Receptor Type 1 Sales Volume, by Application (2017-2028)

    • Table Global Activin Receptor Type 1 Sales Volume Share, by Application (2017-2028)

    • Figure Global Activin Receptor Type 1 Sales Volume Share, by Application (2017-2028)

    • Table Global Activin Receptor Type 1 Sales Value, by Application (2017-2028)

    • Table Global Activin Receptor Type 1 Sales Value Share, by Application (2017-2028)

    • Figure Global Activin Receptor Type 1 Sales Value Share, by Application (2017-2028)

    • Table China Activin Receptor Type 1 Sales Volume, by Application (2017-2028)

    • Table China Activin Receptor Type 1 Sales Volume Share, by Application (2017-2028)

    • Figure China Activin Receptor Type 1 Sales Volume Share, by Application (2017-2028)

    • Table China Activin Receptor Type 1 Sales Value, by Application (2017-2028)

    • Table China Activin Receptor Type 1 Sales Value Share, by Application (2017-2028)

    • Figure China Activin Receptor Type 1 Sales Value Share, by Application (2017-2028)

    • Figure China Activin Receptor Type 1 Production, Import, Consumption and Export (2017-2022)

    • Figure North America Activin Receptor Type 1 Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Activin Receptor Type 1 Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Activin Receptor Type 1 Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Activin Receptor Type 1 Production, Import, Consumption and Export (2017-2022)

    • Table North America Activin Receptor Type 1 Sales Volume, by Type (2017-2028)

    • Table North America Activin Receptor Type 1 Sales Volume Share, by Type (2017-2028)

    • Figure North America Activin Receptor Type 1 Sales Volume Share, by Type (2017-2028)

    • Table North America Activin Receptor Type 1 Sales Volume, by Application (2017-2028)

    • Table North America Activin Receptor Type 1 Sales Volume Share, by Application (2017-2028)

    • Figure North America Activin Receptor Type 1 Sales Volume Share, by Application (2017-2028)

    • Figure United States Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure United States Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure Canada Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Table Europe Activin Receptor Type 1 Sales Volume, by Type (2017-2028)

    • Table Europe Activin Receptor Type 1 Sales Volume Share, by Type (2017-2028)

    • Figure Europe Activin Receptor Type 1 Sales Volume Share, by Type (2017-2028)

    • Table Europe Activin Receptor Type 1 Sales Volume, by Application (2017-2028)

    • Table Europe Activin Receptor Type 1 Sales Volume Share, by Application (2017-2028)

    • Figure Europe Activin Receptor Type 1 Sales Volume Share, by Application (2017-2028)

    • Figure Germany Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure UK Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure UK Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure France Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure France Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure Italy Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure Spain Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure Poland Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure Russia Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Table APAC Activin Receptor Type 1 Sales Volume, by Type (2017-2028)

    • Table APAC Activin Receptor Type 1 Sales Volume Share, by Type (2017-2028)

    • Figure APAC Activin Receptor Type 1 Sales Volume Share, by Type (2017-2028)

    • Table APAC Activin Receptor Type 1 Sales Volume, by Application (2017-2028)

    • Table APAC Activin Receptor Type 1 Sales Volume Share, by Application (2017-2028)

    • Figure APAC Activin Receptor Type 1 Sales Volume Share, by Application (2017-2028)

    • Figure China Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure China Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure Japan Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure India Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure India Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Activin Receptor Type 1 Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Activin Receptor Type 1 Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Activin Receptor Type 1 Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Activin Receptor Type 1 Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Activin Receptor Type 1 Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Activin Receptor Type 1 Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Activin Receptor Type 1 Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Activin Receptor Type 1 Sales Value and Growth Rate (2017-2028)

    • Table Oncodesign SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Oncodesign SA Product Profiles, Application and Specification

    • Table Oncodesign SA Activin Receptor Type 1 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Blueprint Medicines Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Blueprint Medicines Corp Product Profiles, Application and Specification

    • Table Blueprint Medicines Corp Activin Receptor Type 1 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Daiichi Sankyo Company Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Daiichi Sankyo Company Ltd Product Profiles, Application and Specification

    • Table Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Tolero Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Tolero Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table La Jolla Pharmaceutical Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table La Jolla Pharmaceutical Company Product Profiles, Application and Specification

    • Table La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US